Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged Images
Generic Name: cilgavimab/tixagevimab
This medication has been identified as Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged. It is supplied by AstraZeneca.
and belongs to the drug class antiviral combinations. Evusheld 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Evusheld
- Generic Name
- cilgavimab/tixagevimab
- Strength
- 150 mg/1.5 mL (100 mg/mL) cilgavimab and 150 mg/1.5 mL (100 mg/mL) tixagevimab co-packaged
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca
- National Drug Code (NDC)
- 00310-7442
More about Evusheld (cilgavimab / tixagevimab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
